Tongji-Ezhou Study | NCT03845868 | Trialant

Tongji-Ezhou Study | NCT03845868 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Egang hospital physical examination center			Other: Dietary and environmental exposure (Observational study)
Ezhou CDC physical examination center			Other: Dietary and environmental exposure (Observational study)

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Incidence of diabetes	Type 2 diabetes was diagnosed when FPG ≥ 7.0 mmol/L and/or OGTT2h ≥ 11.1 mmol/L, or using diabetic medication (self-report).	5 years
Incidence of metabolic syndrome	Metabolic syndrome is defined as using the updated National Cholesterol Education Program/Adult Treatment Panel III criteria for Asian Americans. These criteria require three or more of the following components: (1) central obesity (waist circumference of ≥90 cm for men or ≥80 cm for women), (2) triglycerides of ≥1.7 mmol/L, (3) HDL-C of <1.03 mmol/L for men or <1.30 mmol/L for women, (4) blood pressure of ≥130/85 mmHg or on medication for hypertension, and (5) fasting glucose of ≥5.6 mmol/L.	5 years
Diabetic complications	Development of diabetic complications	mean follow up of 10 years
Incidence of cardiovascular diseases	Cardiovascular death, stroke, myocardial infarction, heart failure	mean follow up of 10 years

Contacts/Locations Module

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
35091747	Derived	Sun T, Deng Y, Geng X, Fang Q, Li X, Chen L, Zhan M, Li D, Zhu K, Li H, Liu L. Plasma Alkylresorcinol Metabolite, a Biomarker for Whole-Grain Intake, Is Inversely Associated with Risk of Nonalcoholic Fatty Liver Disease in a Case-Control Study of Chinese Adults. J Nutr. 2022 Apr 1;152(4):1052-1058. doi: 10.1093/jn/nxab404.

Condition Browse Module

Intervention Browse Module